The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
MALIGNANT MELANOMA IN ORGAN ALLOGRAFT RECIPIENTS1,2
Abstract
Three groups of tumors were studied. The first group was melanomas inadvertently transmitted from donors. Brain metastases from melanoma were often misdiagnosed in the donors as primary brain tumors or cerebral hemorrhage. Eleven donors provided organs to 20 recipients of whom 3 never manifested evidence of melanoma, 1 showed local spread of tumor beyond the allograft, and 16 had metastases. Of the last group 11 died from melanoma, but 4 patients had complete remissions following transplant nephrectomy and discontinuation of immunosuppressive therapy. The second group was Melanomas treated pretransplantation. Thirty patients had cutaneous melanomas and one an ocular melanoma. Six patients (19%) had recurrences posttransplantation. Three were treated < 2 years pretransplantation, 2 between 2-5 years pretransplantation, and one 120 months pretransplantation. The third group was De novo melanomas. Cutaneous melanomas occurred in 164 patients, melanomas of unknown origin in 8, and ocular melanomas in 5. Melanomas constituted 5.2% of posttransplant skin cancers compared with 2.7% in the general population. Unusual features of cutaneous melanomas were that 6 (4%) occurred in children, and 9 (5%) occurred in bone marrow recipients who were treated for leukemia. Forty-four patients (27%) who had cutaneous melanomas also had other skin cancers. Forty-seven of 68 patients (69%) had thick skin lesions (Clark's level III or greater or > 0.76 mm by Breslow's technique). Lymph node metastases occurred in 32 patients (20%) with cutaneous melanomas. Fifty patients (30%) with cutaneous melanomas died of their malignancies, as did 5 with melanomas of unknown origin, and 1 with ocular melanoma. The risks of melanoma may be reduced by stringent selection of donors; by waiting at least 5 years between treatment of melanoma and undertaking transplantation; and, perhaps, by reducing sunlight exposure and by early excision of suspicious dysplastic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kinlen, L. J., Sheil, A. G., Peto, J., & Doll, R. (1979) · BMJ · doi:10.1136/bmj.2.6203.1461 · Cited by 593
BALCH, C. M., MURAD, T. M., SOONG, S.-J., INGALLS, A. L., HALPERN, N. B., & MADDOX, W. A. (1978) · Annals of Surgery · doi:10.1097/00000658-197812000-00004 · Cited by 576
THE EFFECT OF IMMUNOSUPPRESSION ON PRE-EXISTING CANCERS
PENN, I. (1993) · Transplantation · doi:10.1097/00007890-199304000-00011 · Cited by 340
Self-citation(1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/73.1.75 · Cited by 318
Lennard, L., THOMAS, S., HARRINGTON, C. I., & Maddocks, J. L. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb02408.x · Cited by 97
Sheil, A. G. R. (1986) · World Journal of Surgery · doi:10.1007/bf01655298 · Cited by 87
Cutaneous Malignant Melanoma in Association With Other Skin Cancers
Green, A. C., & OʼRourke, M. G. E. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/74.5.977 · Cited by 81
Clinical Decision Making Rounds At the New England Medical Center
Pauker, S. G. (1984) · Medical Decision Making · doi:10.1177/0272989x8400400112 · Cited by 21
Cuchural, G. J., Levey, A. S., & Pauker, S. G. (1984) · Medical Decision Making · doi:10.1177/0272989x8400400113 · Cited by 18
Cited by
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Natural Innate and Adaptive Immunity to Cancer
Vesely, M. D., Kershaw, M. H., Schreiber, R. D., & Smyth, M. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101324 · Cited by 2,101
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Metadata
- Authors
- Penn, I.
- Venue
- Transplantation
- Published
- 1996-01
- Volume
- 61
- Issue
- 2
- Pages
- 274-278
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2036097587
- Cited by
- 305
- References
- 9
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MALIGNANT MELANOMA IN ORGAN ALLOGRAFT RECIPIENTS1,2. https://app.cochat.ai/papers/10.1097/00007890-199601270-00019
- The paper
- Penn, I. (1996). MALIGNANT MELANOMA IN ORGAN ALLOGRAFT RECIPIENTS1,2. Transplantation. https://doi.org/10.1097/00007890-199601270-00019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.